About the protection of inventions, briefly

TRIPs-Plus Treaties and Strengthening Protection of Pharmaceutical Inventions

After concluding TRIPs agreement, the sphere of negotiation in respect of protecting new kinds of intellectual property rights especially pharmaceutical inventions transferred to bilateral and regional arrangements. TRIPs agreement has some flexibility to attract all countries. Industrialized countries believed that multilateral agreements protections based especially in regard of pharmaceutica...

an investigation about the relationship between insurance lines and economic growth; the case study of iran

مطالعات قبلی بازار بیمه را به صورت کلی در نظر می گرفتند اما در این مطالعه صنعت بیمه به عنوان متغیر مستفل به بیمه های زندگی و غیر زندگی شکسته شده و هم چنین بیمه های زندگی به رشته های مختلف بیمه ای که در بازار بیمه ایران سهم قابل توجهی دارند تقسیم میشود. با استفاده از روشهای اقتصاد سنجی داده های برای دوره های 48-89 از مراکز ملی داده جمع آوری شد سپس با تخمین مدل خود بازگشتی برداری همراه با تعدادی ...

the protection of pharmaceutical inventions and human rights challenges

although intellectual property rights (iprs) in this era specially after the constitution of world trade organization (wto) have been concerned from economic and commercialization point of view, human rights perspective to iprs has been increased and so, human rights groups have highlighted certain challenges between iprs and human rights, have tried to adjust economic perspective and have soug...

A Case for Expansive Patent Protection of Biotechnology Inventions

Patent law protection of inventions in medicine and pharmaceutical industry.

Simply saying, inventions represent new solutions to technical problems. The word “technique” means “restraining of natural forces and controlled use of natural phenomena” , that is “human activity in the field of material phenomena characterized by space, time, matter and energy” . Thus, the technique is, actually, human activity to master and control nature. Once the domain of technique was c...